MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s1473-3099(19)30113-6

Медицинская библиотека · The Lancet. Infectious diseases · 2019

The burden of Legionnaires' disease in New Zealand (LegiNZ): a national surveillance study.

Priest Patricia C, Slow Sandy, Chambers Stephen T, Cameron Claire M, Balm Michelle N, Beale Mark W, Blackmore Timothy K, Burns Andrew D, Drinković Dragana, Elvy Juliet A, Everts Richard J, Hammer David A, Huggan Paul J, Mansell Christopher J, Raeder Vicki M, Roberts Sally A, Robinson Murray C, Sathyendran Vani, Taylor Susan L, Thompson Alyssa W, Ussher James E, van der Linden Antje J, Williams Melanie J, Podmore Roslyn G, Anderson Trevor P, Barratt Kevin, Mitchell Joanne L, Harte David J, Hope Virginia T, Murdoch David R

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Legionnaires' disease is under-diagnosed because of inconsistent use of diagnostic tests and uncertainty about whom to test. We assessed the increase in case detection following large-scale introduction of routine PCR testing of respiratory specimens in New Zealand.

METHODS

LegiNZ was a national surveillance study done over 1-year in which active case-finding was used to maximise the identification of cases of Legionnaires' disease in hospitals. Respiratory specimens from patients of any age with pneumonia, who could provide an eligible lower respiratory specimen, admitted to one of 20 participating hospitals, covering a catchment area of 96% of New Zealand's population, were routinely tested for legionella by PCR. Additional cases of Legionnaires' disease in hospital were identified through mandatory notification.

FINDINGS: Between May 21, 2015, and May 20, 2016, 5622 eligible specimens from 4862 patients were tested by PCR. From these, 197 cases of Legionnaires' disease were detected. An additional 41 cases were identified from notification data, giving 238 cases requiring hospitalisation. The overall incidence of Legionnaires' disease cases in hospital in the study area was 5·4 per 100 000 people per year, and Legionella longbeachae was the predominant cause, found in 150 (63%) of 238 cases.

INTERPRETATION: The rate of notified disease during the study period was three-times the average over the preceding 3 years. Active case-finding through systematic PCR testing better clarified the regional epidemiology of Legionnaires' disease and uncovered an otherwise hidden burden of disease. These data inform local Legionnaires' disease testing strategies, allow targeted antibiotic therapy, and help identify outbreaks and effective prevention strategies. The same approach might have similar benefits if applied elsewhere in the world.

FUNDING: Health Research Council of New Zealand.

Для цитирования: Priest Patricia C, Slow Sandy, Chambers Stephen T, Cameron Claire M, Balm Michelle N, Beale Mark W, Blackmore Timothy K, Burns Andrew D, Drinković Dragana, Elvy Juliet A, Everts Richard J, Hammer David A, Huggan Paul J, Mansell Christopher J, Raeder Vicki M, Roberts Sally A, Robinson Murray C, Sathyendran Vani, Taylor Susan L, Thompson Alyssa W, Ussher James E, van der Linden Antje J, Williams Melanie J, Podmore Roslyn G, Anderson Trevor P, Barratt Kevin, Mitchell Joanne L, Harte David J, Hope Virginia T, Murdoch David R. The burden of Legionnaires' disease in New Zealand (LegiNZ): a national surveillance study.. The Lancet. Infectious diseases. 2019. DOI: 10.1016/s1473-3099(19)30113-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.